Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRD1 | P41143 | 9/20 | 0.67 |
| ▸ | OPRM1 | P35372 | 8/20 | 0.67 |
| ▸ | OPRK1 | P41145 | 7/20 | 0.67 |
| ▸ | MRGPRX2 | Q96LB1 | 2/20 | 0.57 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.57 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.57 |
| ▸ | ARRB1 | P49407 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Desomorphine SCHEMBL678973 | 1.00 | OPRD1 (0.67) | OPRD1OPRM1OPRK1MRGPRX2SLC22A1 | |
| Desomorphine SCHEMBL24969 | 1.00 | OPRD1 (0.67) | OPRD1OPRM1OPRK1MRGPRX2SLC22A1 | |
| Desomorphine SCHEMBL11630127 | 1.00 | OPRD1 (0.67) | OPRD1OPRM1OPRK1MRGPRX2SLC22A1 | |
| Desomorphine SCHEMBL12720171 | 1.00 | OPRD1 (0.67) | OPRD1OPRM1OPRK1MRGPRX2SLC22A1 | |
| SCHEMBL15866691 | 0.94 | OPRD1 (0.60) | OPRD1OPRM1OPRK1MRGPRX2SLC22A1 | |
| SCHEMBL16866227 | 0.94 | OPRD1 (0.60) | OPRD1OPRM1OPRK1MRGPRX2SLC22A1 | |
| SCHEMBL11631069 | 0.85 | OPRM1 (0.67) | OPRD1OPRM1OPRK1MRGPRX2 | |
| SCHEMBL21202077 | 0.85 | OPRM1 (0.67) | OPRD1OPRM1OPRK1MRGPRX2 | |
| SCHEMBL21202024 | 0.85 | OPRM1 (0.67) | OPRD1OPRM1OPRK1MRGPRX2 | |
| SCHEMBL11631074 | 0.85 | OPRM1 (0.67) | OPRD1OPRM1OPRK1MRGPRX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 183 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115885037-A | Midbrain organoid, high-speed large-scale production method thereof, method for screening neurotoxic substance and method for screening dopaminergic neuron-related disease drug using the same | 广东省奥干诺伊德生物科技有限公司 | 2023-03-31 | — | — | CN | claimed |
| CN-112402386-B | Abuse-preventing opioid oral sustained-release tablet and preparation method thereof | 江苏恩华药业股份有限公司 | 2022-06-28 | — | — | CN | claimed |
| CN-113840621-A | Vaccination and antibody generation platform | 德国癌症研究公共权益基金会 | 2021-12-24 | — | — | CN | claimed |
| CN-112840018-A | Method for inducing differentiation of dopamine neural precursor cells from stem cells | S生物医药公司 | 2021-05-25 | — | — | CN | claimed |
| CN-112402386-A | Abuse-proof opioid oral sustained release tablet and preparation method thereof | 江苏恩华药业股份有限公司 | 2021-02-26 | — | — | CN | claimed |
| CN-110831575-A | Pharmaceutical preparation | 卡里亚制药控股有限公司 | 2020-02-21 | — | — | CN | claimed |
| CN-102406640-A | Analgesic and antiphlogistic medicines and micro-needle transdermal administration method for same | SHANGHAI TAIYIN BIOLOG TECHNOLOGY CO LTD | 2012-04-11 | — | — | CN | claimed |
| CN-100409847-C | Transdermal delivery system for alkaloids of aconitum species | XEL HERBACEUTICALS (US) | 2008-08-13 | — | — | CN | claimed |
| CN-1450883-A | Transdermal delivery system for alkaloids of aconitum species | XEL HERBACEUTICALS (US) | 2003-10-22 | — | — | CN | claimed |
| CN-1069544-C | Thebaica giving-up vaccinum for man | KUNMING BIOLOG TECH ENGINEERIN (CN) | 2001-08-15 | — | — | CN | claimed |
| CN-1294519-A | Pharmaceutical composition containing a compound having an activity of promoting the absorption of an active ingredient | INPHARMA SA (CH) | 2001-05-09 | — | — | CN | claimed |
| CN-1196955-A | Thebaica giving-up vaccinum for man | KUNMING BIOLOG TECH ENGINEERIN (CN) | 1998-10-28 | — | — | CN | claimed |
| CN-119524126-A | Pharmaceutical resinated compositions and methods of making and using the same | 罗兹制药公司 | 2025-02-28 | — | — | CN | disclosed |
| WO-2024194018-A1 | METHOD FOR PRODUCING CORYTUBERINE AND SALUTARIDINE | Universität Graz (AT) | 2024-09-26 | — | — | WO | disclosed |
| EP-4431612-A1 | PROCESS FOR THE PREPARATION OF CORORYLOURIN AND SALUTARIDINE | Universität Graz (AT) | 2024-09-18 | — | — | EP | disclosed |
| CN-118234483-A | Compositions and methods for infusing a drug into the bladder | 特瑞纲制药有限公司 | 2024-06-21 | — | — | CN | disclosed |
| CN-1450883-A | Transdermal delivery system for alkaloids of aconitum species | XEL HERBACEUTICALS (US) | 2003-10-22 | — | — | CN | disclosed |
| CN-1069544-C | Thebaica giving-up vaccinum for man | KUNMING BIOLOG TECH ENGINEERIN (CN) | 2001-08-15 | — | — | CN | disclosed |
| CN-1294519-A | Pharmaceutical composition containing a compound having an activity of promoting the absorption of an active ingredient | INPHARMA SA (CH) | 2001-05-09 | — | — | CN | disclosed |
| CN-1196955-A | Thebaica giving-up vaccinum for man | KUNMING BIOLOG TECH ENGINEERIN (CN) | 1998-10-28 | — | — | CN | disclosed |